Randomised placebo controlled trial of aspirin and dipyridamole in the prevention of coronary vein graft occlusion.

Treatment with the combination of aspirin and dipyridamole is believed to reduce the incidence of coronary vein graft occlusion. A double blind randomised controlled trial was carried out in which aspirin 990 mg and dipyridamole 225 mg daily or placebo were added to the routine postoperative managem...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Br Heart J
Principais autores:	Brooks, N, Wright, J, Sturridge, M, Pepper, J, Magee, P, Walesby, R, Layton, C, Honey, M, Balcon, R
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMJ Publishing Group 1985
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC481740/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3881108/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/hrt.53.2.201
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!